Akero Therapeutics Inc (AKRO)
19.90
0.00 (0.00%)
USD |
NASDAQ |
May 01, 14:22
Akero Therapeutics Accounts Payable (Quarterly): 7.038M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 7.038M |
September 30, 2023 | 11.45M |
June 30, 2023 | 10.12M |
March 31, 2023 | 7.08M |
December 31, 2022 | 7.968M |
September 30, 2022 | 6.01M |
June 30, 2022 | 6.877M |
March 31, 2022 | 4.45M |
December 31, 2021 | 6.706M |
September 30, 2021 | 6.784M |
June 30, 2021 | 2.307M |
Date | Value |
---|---|
March 31, 2021 | 4.605M |
December 31, 2020 | 3.428M |
September 30, 2020 | 4.636M |
June 30, 2020 | 2.536M |
March 31, 2020 | 1.535M |
December 31, 2019 | 0.947M |
September 30, 2019 | 0.093M |
June 30, 2019 | 3.248M |
March 31, 2019 | 0.952M |
December 31, 2018 | 1.373M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.093M
Minimum
Sep 2019
11.45M
Maximum
Sep 2023
5.149M
Average
4.636M
Median
Sep 2020
Accounts Payable (Quarterly) Benchmarks
Madrigal Pharmaceuticals Inc | 28.04M |
89bio Inc | 8.585M |
Viking Therapeutics Inc | 5.225M |
Eli Lilly and Co | 2.599B |
Ionis Pharmaceuticals Inc | 26.03M |